Main clinical features of the 31 patients
. | N (%) . | Median (range) . |
|---|---|---|
| Monoclonal protein | ||
| κ | 5 (16) | — |
| λ | 24 (78) | — |
| Biclonal | 2 (6) | — |
| Organ involvement | ||
| Kidney | 22 (71) | — |
| Heart | 12 (38) | — |
| Liver | 7 (23) | — |
| Skin | 3 (10) | — |
| Gastrointestinal tract | 3 (10) | — |
| Two or more organs involved | 19 (61) | — |
| Postural hypotension | 7 (23) | — |
| Urinary protein loss, g/24 h | — | 4 (0-29) |
| Patients with urinary protein loss > 3 g/24 h | 18 (58) | — |
| Serum creatinine concentration, mg/dL | — | 1.1 (0.6-6.8) |
| Patients with serum creatinine concentration > 2 mg/dL | 7 (23) | — |
| Interventricular septum (IVS) thickness, mm | — | 14 (8-19) |
| Patients with interventricular septum (IVS) thickness > 15 mm | 5 (16) | — |
| Ejection fraction, % | — | 55 (35-72) |
| Patients with ejection fraction < 45% | 6 (19) | — |
. | N (%) . | Median (range) . |
|---|---|---|
| Monoclonal protein | ||
| κ | 5 (16) | — |
| λ | 24 (78) | — |
| Biclonal | 2 (6) | — |
| Organ involvement | ||
| Kidney | 22 (71) | — |
| Heart | 12 (38) | — |
| Liver | 7 (23) | — |
| Skin | 3 (10) | — |
| Gastrointestinal tract | 3 (10) | — |
| Two or more organs involved | 19 (61) | — |
| Postural hypotension | 7 (23) | — |
| Urinary protein loss, g/24 h | — | 4 (0-29) |
| Patients with urinary protein loss > 3 g/24 h | 18 (58) | — |
| Serum creatinine concentration, mg/dL | — | 1.1 (0.6-6.8) |
| Patients with serum creatinine concentration > 2 mg/dL | 7 (23) | — |
| Interventricular septum (IVS) thickness, mm | — | 14 (8-19) |
| Patients with interventricular septum (IVS) thickness > 15 mm | 5 (16) | — |
| Ejection fraction, % | — | 55 (35-72) |
| Patients with ejection fraction < 45% | 6 (19) | — |
— indicates not applicable.